Patent application number | Description | Published |
20090148575 | PACKAGING MATERIAL COMPRISING A COATING WITH MICROCAPSULES - The present invention relates to a packaging material in the form of a composite comprising at least one paper or cardboard support applied atop which there are at least one paper coating slip layer, if appropriate a print layer, if appropriate one or more thermoplastic layers and if appropriate one or more further layers, wherein at least one of the applied layers comprises microencapsulated latent heat storage material and the capsule wall of the microencapsulated latent heat storage material is constructed from | 06-11-2009 |
20100063171 | METHOD FOR PRODUCING EMULSION POLYMERS - The present invention relates to a process for preparing emulsion polymer particles having a core/shell structure and also to their use in paints, paper coatings, foams, and cosmetics. | 03-11-2010 |
20100255321 | AQUEOUS POLYMER DISPERSIONS, PROCESSES FOR PREPARING THEM, AND THEIR USE - The present invention relates to an aqueous polymer dispersion whose dispersed addition polymer P comprises, copolymerized in free-radically polymerized form, at least one polar monomer having a water solubility of greater than 50 g/liter (measured at 20° C.), and obtainable by free-radically initiated aqueous emulsion polymerization, the polar monomer being metered to the reaction mixture during the polymerization process at a variable, i.e., nonconstant rate, for example in the sense of a rate gradient. The present invention further relates to processes for preparing these aqueous polymer dispersions, to their use as binders and/or in coatings, and also to coatings comprising the polymer dispersion of the invention. | 10-07-2010 |
20110039995 | METHOD FOR IMPROVING THE STORAGE STABILITY OF AQUEOUS COMPOSITE PARTICLE DISPERSIONS - The invention provides a process for improving the storage stability of aqueous composite-particle dispersions and of aqueous formulations comprising them. | 02-17-2011 |
20110143923 | TITANIUM DIOXIDE COMPOSITION COMPRISING TITANIUM DIOXIDE NANOPARTICLES, AND PREPARATION AND USE THEREOF - The present invention relates to a titanium dioxide composition which comprises titanium dioxide nanoparticles, its preparation and use. | 06-16-2011 |
20110184088 | COATING MATERIALS COMPRISING COMPOSITE PARTICLES - The present invention relates to a coating material in the form of an aqueous composition comprising:
| 07-28-2011 |
20120016060 | PROCESS FOR PREPARING AN AQUEOUS COMPOSITE-PARTICLE DISPERSION - A process for preparing stable aqueous dispersions of composite particles. | 01-19-2012 |
20120041112 | PROCESS FOR IMPROVING THE STORAGE STABILITY OF AQUEOUS COMPOSITE-PARTICLE DISPERSIONS - The invention provides a process for improving the storage stability of aqueous composite-particle dispersions and of aqueous formulations comprising them. | 02-16-2012 |
20120121921 | AQUEOUS POLYMER DISPERSION AS A BINDING AGENT FOR PLASTERS AND COATING MATERIALS HAVING IMPROVED FIRE BEHAVIOR - Use of an aqueous polymer dispersion comprising at least one polymer (P), obtainable by free radical emulsion polymerization of at least one ethylenically unsaturated monomer (M1) and from 20 to 75% by weight of tert-butyl (meth)acrylate, as a binder in construction chemistry products. | 05-17-2012 |
20120157577 | MULTISTAGE POLYMER DISPERSIONS, PROCESSES FOR PREPARING THEM, AND USE THEREOF - The present invention relates to aqueous multistage polymer dispersions obtainable by free-radically initiated aqueous emulsion polymerization, having a soft phase and a hard phase, and a hard-to-soft stage ratio of 25% to 95% by weight to 75% to 5% by weight, the glass transition temperature (Tg) of the soft phase, as first stage, being −30 to 0° C. and that of the hard phase, as second stage, being 20 to 60° C., comprising at least one monomer of the general formula I | 06-21-2012 |
20120196116 | GYPSUM WALL BOARD CONTAINING MICRO-ENCAPSULATED LATENT HEAT ACCUMULATOR MATERIALS - The present invention relates to a gypsum construction board comprising two covering layers and a gypsum core, where the gypsum core comprises microcapsules with a lipophilic capsule core and a capsule wall formed from
| 08-02-2012 |
20120208958 | AQUEOUS POLYMER DISPERSIONS, PROCESSES FOR PREPARING THEM, AND THEIR USE - The present invention relates to an aqueous polymer dispersion whose dispersed addition polymer P comprises, copolymerized in free-radically polymerized form, at least one polar monomer having a water solubility of greater than | 08-16-2012 |
20150104658 | USE OF MULTI-STAGE POLYMERIZATE DISPERSIONS TO COAT METAL SHEETS - The present invention relates to the use of aqueous multistage polymer dispersions obtainable by free-radically initiated aqueous emulsion polymerization, having a soft phase and a hard phase and having a hard-to-soft stage ratio of 25% to 95% by weight to 75% to 5% by weight, the glass transition temperature (Tg) of the soft phase, as first stage, being −30 to 0° C. and that of the hard phase, as second stage, being 20 to 60° C., comprising at least one monomer of the general formula I | 04-16-2015 |
Patent application number | Description | Published |
20110151411 | DENTAL APPLIANCE, PROCESS FOR PRODUCING A DENTAL APPLIANCE AND USE THEREOF - The invention relates to a process for producing a dental appliance, the process comprising the steps of a) providing a mixture of a liquid, an inorganic binder precursor being able to undergo a sol/gel reaction and a glass or glass ceramic powder, b) casting the mixture into a mould, c) drying the cast mixture in the mould to obtain a machinable dental appliance, d) optionally machining the dental appliance to obtain a dental workpiece, e) optionally removing the dental appliance or dental workpiece from the mould, f) optionally sintering the dental appliance or dental workpiece and to a dental appliance obtainable by such a process. | 06-23-2011 |
20110236860 | Dental Ceramic Article, Process for Production and Use Thereof - The invention describes a dental article comprising zirconium oxide and at least two different colouring substances A and B, substance A showing a light emission in the range of about 470 nm to about 510 nm and substance B showing a light absorption in the range from about 520 nm to about 750 nm. The invention also relates to different processes of producing the dental article e.g. by a process comprising a casting step, a pressing step, or an infiltration step and to the use of certain compositions containing either substance A or substance B for producing such a dental article. | 09-29-2011 |
20120175801 | SYSTEMS AND METHODS FOR MAKING LAYERED DENTAL APPLIANCES FROM THE OUTSIDE IN - A system and method for making a layered dental appliance. The system can include a first portion comprising a negative of a first layer of a layered dental appliance, and a second portion comprising a positive shape of a second layer of the layered dental appliance. The method can include providing a mold comprising a negative of an outer shape of a layered dental appliance, and positioning a slurry in the mold, forming a first layer of the layered dental appliance. The method can further include providing a solid structure comprising a positive shape of a second layer of the layered dental appliance, and pressing the solid structure into the slurry in the mold. | 07-12-2012 |
20120175802 | SYSTEMS AND METHODS FOR MAKING LAYERED DENTAL APPLIANCES - A system and method for making a layered dental appliance. The system can include a first mold comprising a negative of a first layer of a layered dental appliance, a second mold comprising a negative of a second layer, and a dental core dimensioned to be at least partially received in the first mold and the second mold. The method can include positioning a first slurry in the first mold, and pressing the dental core into the first slurry to form a first article comprising the dental core and a first layer formed from the first slurry. The method can further include removing the first article from the first mold, positioning a second slurry in the second mold, and pressing the first article into the second slurry to form a second article comprising the dental core, the first layer, and a second layer formed from the second slurry. | 07-12-2012 |
20120193823 | SYSTEMS AND METHODS FOR MAKING LAYERED DENTAL APPLIANCES - A system and method for making a layered dental appliance. The system can include a mold comprising a negative of an outer shape of a layered dental appliance, and a dental core dimensioned to be at least partially received in the mold. The method can include positioning a first slurry in the mold, and pressing the dental core into the first slurry in the mold to form a first article comprising the dental core and a first layer formed from the first slurry. The method can further include removing the first article from the mold, and firing the first article. The method can further include positioning a second slurry in the mold, and pressing the first article into the second slurry in the mold to form a second article comprising the dental core, the first layer, and a second layer formed from the second slurry. | 08-02-2012 |
20120276295 | SYSTEMS AND METHODS FOR MAKING MONOLITHIC GEL BODIES - Systems and methods for making a monolithic gel body. Some systems can include a substrate, a sol, an ammonia atmosphere. Some methods can include applying a first quantity of the sol to the substrate to form a first coated substrate, and positioning the first coated substrate in the ammonia atmosphere to cure the first quantity of sol to form a first supported gel comprising a first gel supported by the substrate. Such methods can further include applying a second quantity of the sol to the first supported gel to form a second coated substrate comprising the second quantity of sol and the first supported gel. Some methods can include positioning the substrate in the ammonia atmosphere while applying the sol onto the substrate to form a monolithic gel body by a layering process. | 11-01-2012 |
20120285019 | METHODS FOR MAKING LAYERED DENTAL APPLIANCES - Method for making a layered dental restoration, the method includes providing a solid structure (e.g., a die or a dental core, such as a fully sintered ceramic dental core) having a desired outer shape, and applying a first slurry to the solid structure to form a first free form layer on the solid structure. The method further include solidifying the first free form layer on the solid structure, and machining the solidified first free form layer to a desired shape to form a first article comprising the solid structure and a first shaped layer. The method can further include applying, solidifying, and machining a second layer in a similar way to form a second article comprising the solid structure, the first shaped layer, and a second shaped layer. The free form layers need not be exposed to a high temperature prior to being machined. | 11-15-2012 |
20130059272 | DENTAL CERAMIC ARTICLE, PROCESS FOR PRODUCTION AND USE THEREOF - The invention relates to a dental article comprising two sections, section A and section B, section A having an upper and a lower surface portion, section A comprising zirconia in an amount of at least about 80 mol %, a stabilizer and a component X comprising Dy or Sm or Eu or mixtures thereof, section B comprising a glass, glass ceramic or composite material, section B being located above the upper surface portion of section A. | 03-07-2013 |
20130180110 | METHODS FOR MAKING LAYERED DENTAL APPLIANCES - Methods for making a layered dental appliance. Some methods of the present disclosure can include providing a solid structure (e.g., a die or a dental core, such as a fully sintered ceramic dental core) having a desired outer shape, and applying a slurry to the solid structure to form a first free form layer on the solid structure. The slurry can include at least one of a glass and a glass ceramic. The method can further include firing the first free form layer on the solid structure, and machining the fired first free form layer to a desired shape to form a first article comprising the solid structure and a first shaped layer. Some methods can further include additional applying, firing, and machining steps to achieve a resulting dental appliance having a desired number of layers. Some methods can include removing the solid structure. | 07-18-2013 |
20140178834 | COLOURING SOLUTION FOR SELECTIVELY TREATING THE SURFACE OF DENTAL CERAMIC AND RELATED METHODS - The invention relates to a solution to be selectively applied to individual parts of the surface of dental ceramic(s) and a process for using the solution in the dental field. More specifically the invention relates to a solution comprising a) a solvent, b) an effect agent, and c) a complexing agent. The invention also relates to a kit comprising the solution and to a method of using the solution for selectively treating of parts of the surface dental ceramic(s). The invention also relates to a application instrument suitable for applying the solution. | 06-26-2014 |
20140377718 | DENTAL MILLING BLOCK CONTAINING INDIVIDUALIZED DENTAL ARTICLE AND PROCESS OF PRODUCTION - The invention relates to a dental milling block ( | 12-25-2014 |
20150223917 | COLORING SOLUTION FOR ZIRCONIA CERAMICS - The invention relates to kit of parts comprising a coloring solution, a porous zirconia article, optionally application equipment, the solution comprising cation(s) of coloring agent(s) in an amount above about 0.05 mol/l, solvent(s) for the ion(s), optionally complexing agent(s), optionally thickening agent(s), optionally organic marker substance(s), optionally additive(s), the porous zirconia article showing a N2 adsorption and desorption of isotherm type IV according to IUPAC classification. The invention also relates to a method for coloring a zirconia article comprising the steps of providing a porous zirconia article and a coloring solution, applying the coloring solution to at least a part of the outer surface of the porous zirconia article, optionally drying the porous zirconia article of the preceding step, sintering the porous zirconia article to obtain a colored zirconia ceramic article. | 08-13-2015 |
20150282905 | MULTI SECTIONAL DENTAL ZIRCONIA MILLING BLOCK, PROCESS OF PRODUCTION AND USE THEREOF - The invention relates to a porous dental milling block comprising at least two geometrically defined Material Sections A and B, Material Section A comprising a tetragonal zirconia crystal phase in an amount A-T in % and a cubic zirconia crystal phase in an amount A-C in %, Material Section B comprising cubic zirconia crystal phase in an amount B-T in % and cubic zirconia crystal phase in an amount B-C in %, wherein (amount of tetragonal phase A-T in %)/(amount of cubic phase content A-C in %)>1 and (amount of tetragonal phase content B-T in %)/(amount of cubic phase content B-C in %)<1. The invention also relates to a process of production of the porous dental milling block and its use for producing a dental article. | 10-08-2015 |
Patent application number | Description | Published |
20090215675 | Means for the inhibition of anti-beta1-adrenergic receptor antibodies - The present invention is related to a peptide selected from the group comprising a) a cyclic peptide of formula (I): Cyclo(AIa-x-x-x-x-x-x-x-x-x-Cys-x-x-x-Pro-x-Cys-Cys-xk-GIn), (I) whereby k is any integer from 0 to 6, preferably any integer from 1 to 6, more preferably k=6; b) a cyclic peptide of formula (II): Cyclo(Ala-x-x-Trp-x-x-Gly-x-Phe-x-Cys-xh-Gln), (II) whereby h is any integer from 0 to 2, preferably 1 or 2; c) a cyclic peptide of formula (III): Cyclo(AIa-x-x-x-x-x-x-x-x-x-Cys-xj-Cys-x-x-x-Pro-x-Cys-Cys-xi-Gln); (HI) whereby j is any integer from 0 to 4, preferably j=4; whereby i is any integer from 0 to 6, preferably any integer from 1 to 6, more preferably i−6; and d) a peptide of formula (IV): Ala-x1-Cys-xm-Cys-x-x-x-Pro-x-Cys-Cys-xn-Gln, (IV) whereby 1 is any integer from 0 to 9, preferably any integer from 1 to 9, more preferably n=9; whereby m is any integer from 0 to 4, preferably any integer from 1 to 4, more preferably m=4; whereby n is any integer from O to 6, preferably any integer from 1 to 6, more preferably n=6; whereby x is any amino acid, preferably any naturally occurring amino acid, more preferably any naturally occurring L-amino acid. | 08-27-2009 |
20100209445 | MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING BETA1-ADRENOCEPTOR ANTIBODIES - The present invention relates to novel β-AR homologous cyclopeptide-mutants comprising only two cysteine residues able to form an intramolecular linkage, to linear peptides that can form these cyclopeptide-mutants and to nucleic acid molecules encoding these cyclopeptide-mutants and linear peptides. Moreover, vectors and recombinant host cells comprising said nucleic acid molecule and a method for producing the disclosed cyclopeptide-mutants are provided. Further provided is a composition comprising the peptides, nucleic acid molecules, vectors or host cells of the invention. The present invention also relates to therapeutic and diagnostic means, methods and uses taking advantage of the peptides of the invention and to means, methods and uses for detecting anti-β-adrenergic receptor antibodies like anti-βradrenergic receptor antibodies. | 08-19-2010 |
20120288513 | Means for the inhibition of anti-beta1-adrenergic receptor antibodies - Embodiments of the present invention provide for novel peptides of use for detection and/or inhibition of anti-β1-adrenergic receptor antibodies. Certain embodiments concern uses of cyclic and/or linear peptides. In other embodiments, the present invention relates to novel peptides of use in diagnostic and/or pharmaceutical compositions. Some embodiments concern diagnosing and/or treating cardiac conditions. Cardiac conditions of the instant invention can concern infectious heart disease, non-infectious heart disease, ischemic heart disease, non-ischemic heart disease, inflammatory heart disease, myocarditis, cardiac dilatation, idiopathic cardiomyopathy, idiopathic dilated cardiomyopathy, immune-cardiomyopathy, heart failure, and any cardiac arrhythmia condition. | 11-15-2012 |
20120288870 | Means for the inhibition of anti-beta1-adrenergic receptor antibodies - Embodiments of the present invention provide for novel peptides of use for detection and/or inhibition of anti-β1-adrenergic receptor antibodies. Certain embodiments concern uses of cyclic and/or linear peptides. In other embodiments, the present invention relates to novel peptides of use in diagnostic and/or pharmaceutical compositions. Some embodiments concern diagnosing and/or treating cardiac conditions. Cardiac conditions of the instant invention can concern infectious heart disease, non-infectious heart disease, ischemic heart disease, non-ischemic heart disease, inflammatory heart disease, myocarditis, cardiac dilatation, idiopathic cardiomyopathy, idiopathic dilated cardiomyopathy, immune-cardiomyopathy, heart failure, and any cardiac arrhythmia condition. | 11-15-2012 |
20150038673 | MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING BETA1-ADRENOCEPTOR ANTIBODIES - The present invention relates to novel β-AR homologous cyclopeptide-mutants comprising only two cysteine residues able to form an intramolecular linkage, to linear peptides that can form these cyclopeptide-mutants and to nucleic acid molecules encoding these cyclopeptide-mutants and linear peptides. Moreover, vectors and recombinant host cells comprising said nucleic acid molecule and a method for producing the disclosed cyclopeptide-mutants are provided. Further provided is a composition comprising the peptides, nucleic acid molecules, vectors or host cells of the invention. The present invention also relates to therapeutic and diagnostic means, methods and uses taking advantage of the peptides of the invention and to means, methods and uses for detecting anti-.beta.-adrenergic receptor antibodies like anti-β | 02-05-2015 |
Patent application number | Description | Published |
20100209445 | MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING BETA1-ADRENOCEPTOR ANTIBODIES - The present invention relates to novel β-AR homologous cyclopeptide-mutants comprising only two cysteine residues able to form an intramolecular linkage, to linear peptides that can form these cyclopeptide-mutants and to nucleic acid molecules encoding these cyclopeptide-mutants and linear peptides. Moreover, vectors and recombinant host cells comprising said nucleic acid molecule and a method for producing the disclosed cyclopeptide-mutants are provided. Further provided is a composition comprising the peptides, nucleic acid molecules, vectors or host cells of the invention. The present invention also relates to therapeutic and diagnostic means, methods and uses taking advantage of the peptides of the invention and to means, methods and uses for detecting anti-β-adrenergic receptor antibodies like anti-βradrenergic receptor antibodies. | 08-19-2010 |
20120288513 | Means for the inhibition of anti-beta1-adrenergic receptor antibodies - Embodiments of the present invention provide for novel peptides of use for detection and/or inhibition of anti-β1-adrenergic receptor antibodies. Certain embodiments concern uses of cyclic and/or linear peptides. In other embodiments, the present invention relates to novel peptides of use in diagnostic and/or pharmaceutical compositions. Some embodiments concern diagnosing and/or treating cardiac conditions. Cardiac conditions of the instant invention can concern infectious heart disease, non-infectious heart disease, ischemic heart disease, non-ischemic heart disease, inflammatory heart disease, myocarditis, cardiac dilatation, idiopathic cardiomyopathy, idiopathic dilated cardiomyopathy, immune-cardiomyopathy, heart failure, and any cardiac arrhythmia condition. | 11-15-2012 |
20120288870 | Means for the inhibition of anti-beta1-adrenergic receptor antibodies - Embodiments of the present invention provide for novel peptides of use for detection and/or inhibition of anti-β1-adrenergic receptor antibodies. Certain embodiments concern uses of cyclic and/or linear peptides. In other embodiments, the present invention relates to novel peptides of use in diagnostic and/or pharmaceutical compositions. Some embodiments concern diagnosing and/or treating cardiac conditions. Cardiac conditions of the instant invention can concern infectious heart disease, non-infectious heart disease, ischemic heart disease, non-ischemic heart disease, inflammatory heart disease, myocarditis, cardiac dilatation, idiopathic cardiomyopathy, idiopathic dilated cardiomyopathy, immune-cardiomyopathy, heart failure, and any cardiac arrhythmia condition. | 11-15-2012 |
Patent application number | Description | Published |
20090215675 | Means for the inhibition of anti-beta1-adrenergic receptor antibodies - The present invention is related to a peptide selected from the group comprising a) a cyclic peptide of formula (I): Cyclo(AIa-x-x-x-x-x-x-x-x-x-Cys-x-x-x-Pro-x-Cys-Cys-xk-GIn), (I) whereby k is any integer from 0 to 6, preferably any integer from 1 to 6, more preferably k=6; b) a cyclic peptide of formula (II): Cyclo(Ala-x-x-Trp-x-x-Gly-x-Phe-x-Cys-xh-Gln), (II) whereby h is any integer from 0 to 2, preferably 1 or 2; c) a cyclic peptide of formula (III): Cyclo(AIa-x-x-x-x-x-x-x-x-x-Cys-xj-Cys-x-x-x-Pro-x-Cys-Cys-xi-Gln); (HI) whereby j is any integer from 0 to 4, preferably j=4; whereby i is any integer from 0 to 6, preferably any integer from 1 to 6, more preferably i−6; and d) a peptide of formula (IV): Ala-x1-Cys-xm-Cys-x-x-x-Pro-x-Cys-Cys-xn-Gln, (IV) whereby 1 is any integer from 0 to 9, preferably any integer from 1 to 9, more preferably n=9; whereby m is any integer from 0 to 4, preferably any integer from 1 to 4, more preferably m=4; whereby n is any integer from O to 6, preferably any integer from 1 to 6, more preferably n=6; whereby x is any amino acid, preferably any naturally occurring amino acid, more preferably any naturally occurring L-amino acid. | 08-27-2009 |
20100209445 | MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING BETA1-ADRENOCEPTOR ANTIBODIES - The present invention relates to novel β-AR homologous cyclopeptide-mutants comprising only two cysteine residues able to form an intramolecular linkage, to linear peptides that can form these cyclopeptide-mutants and to nucleic acid molecules encoding these cyclopeptide-mutants and linear peptides. Moreover, vectors and recombinant host cells comprising said nucleic acid molecule and a method for producing the disclosed cyclopeptide-mutants are provided. Further provided is a composition comprising the peptides, nucleic acid molecules, vectors or host cells of the invention. The present invention also relates to therapeutic and diagnostic means, methods and uses taking advantage of the peptides of the invention and to means, methods and uses for detecting anti-β-adrenergic receptor antibodies like anti-βradrenergic receptor antibodies. | 08-19-2010 |
20150038673 | MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING BETA1-ADRENOCEPTOR ANTIBODIES - The present invention relates to novel β-AR homologous cyclopeptide-mutants comprising only two cysteine residues able to form an intramolecular linkage, to linear peptides that can form these cyclopeptide-mutants and to nucleic acid molecules encoding these cyclopeptide-mutants and linear peptides. Moreover, vectors and recombinant host cells comprising said nucleic acid molecule and a method for producing the disclosed cyclopeptide-mutants are provided. Further provided is a composition comprising the peptides, nucleic acid molecules, vectors or host cells of the invention. The present invention also relates to therapeutic and diagnostic means, methods and uses taking advantage of the peptides of the invention and to means, methods and uses for detecting anti-.beta.-adrenergic receptor antibodies like anti-β | 02-05-2015 |